Single Cell Analysis Market: Global Market Estimation, Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Single Cell Analysis Market: by Product Type (Assay Kits, Reagents, Beads, Micro Plates, and Others), By Cell Type (Animal Cell, Microbial Cell, and Plant cell), By Technique (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Microscopy, Flow Cytometry, Spectrophotometry, and Others), By Application (Research Application and Medical Application), By End User (Hospitals and Diagnostic Laboratories, IVF Centers and Cell Banks, Academic and Research Laboratories, Biopharmaceuticals and Biotechnology companies) and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global single cell analysis market was valued at USD 2400 million in 2021 and estimated to touch USD 5050 million by 2027 growing at a CAGR of 13.2% during the forecast period 2021 to 2027. Single cell analysis is a technology helps to sequence the whole human genome at the single cell level. Single cell analysis includes proteomics, genomics, metabolomics, epigenomics, and transcriptomics. Single cell analysis is carried to analyze and measure the cellular heterogeneity and to define the specific cell type or cell state in the given population. This technique has immense applications in the field of medicine by interpreting life at fundamental level. Cancer is one of the leading causes of death worldwide. The disease has seen tremendous expansion in recent decades and is predicted to continue to do so during the forecast period. According to the Globocan 2020 information sheet, there were an anticipated 19,292,789 new cancer cases identified globally, with about 9,958,133 cancer-related deaths. Furthermore, the International Agency for Research on Cancer (IARC) predicts that by 2040, the global burden of cancer would have increased to 27.5 million new cancer cases and 16.3 million deaths. Furthermore, single-cell analysis market is projected to standardise and automate workflows in clinical diagnostics, providing significant information for real-time cancer monitoring and, eventually, new therapeutic methods for the benefit of patients. This feature is expected to result in more effective and thorough analysis. As a result, increased spending in cancer research is expected to be one of the market’s primary driving forces over the forecast period. The high cost of single-cell analysis devices, on the other hand, is projected to limit the market’s expansion.

Single Cell Analysis Market

MARKET SUMMARY
-
13.2% CAGR
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 13.2%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Single Cell Analysis Market

  • The report on global Single Cell Analysis Market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, cell type, technique, application, distribution channel and geography.
  • Single Cell Analysis Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Merck KGaA (Germany)
  • Danaher Corporation (U.S.)
  • Agilent Technologies (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
Dynamics

Single Cell Analysis Market

Increase in the prevalence of infectious diseases and chronic diseases such as cancer, immunological, and neurological disorders are anticipated to drive the global market over the forecast years. Rise in government funding for cell-based research, technological advancements in the single cell analysis instruments, rise in focus on personalized medicine, and rise in R&D activities in biotechnology and pharmaceutical sectors are expected to propel the market. However, high cost of R&D, lack of skilled professionals, and ethical and legal issues in the interpretation may hamper the growth of the market.


North-America got significant share

Single Cell Analysis Market

Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America single cell analysis market growth driven by increase in the R&D activities by the biotechnology and biopharmaceutical companies, rise in prevalence of chronic diseases such as cancer, and government initiatives such as single cell analysis program by National Institute of Health (U.S.) to overcome the challenges in this technique are expected to boost the market. Europe single cell analysis market has a lucrative growth, which is attributed to establishment of biopharmaceutical and biotechnology companies, rise in preference for personalized medicine, and increase in government funding for the cell-based research are expected to propel the market. However, a prominent growth observed in Asia Pacific single cell analysis market due to escalation in medical tourism, large patient pool, and development in healthcare infrastructure are expected to drive the revenue of market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0

Single Cell Analysis Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Merck KGaA (Germany)
  • Danaher Corporation (U.S.)
  • Agilent Technologies (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • General Electric Company (U.K.)
  • Bio-Rad Laboratories, Inc.(U.S.)
  • Illumina, Inc. (U.S.)
  • NuGEN Technologies Inc. (U.S.)
  • 10x Genomics(U.S.)

Description

The global single cell analysis market was valued at USD 2400 million in 2021 and estimated to touch USD 5050 million by 2027 growing at a CAGR of 13.2% during the forecast period 2021 to 2027. Single cell analysis is a technology helps to sequence the whole human genome at the single cell level. Single cell analysis includes proteomics, genomics, metabolomics, epigenomics, and transcriptomics. Single cell analysis is carried to analyze and measure the cellular heterogeneity and to define the specific cell type or cell state in the given population. This technique has immense applications in the field of medicine by interpreting life at fundamental level. Cancer is one of the leading causes of death worldwide. The disease has seen tremendous expansion in recent decades and is predicted to continue to do so during the forecast period. According to the Globocan 2020 information sheet, there were an anticipated 19,292,789 new cancer cases identified globally, with about 9,958,133 cancer-related deaths. Furthermore, the International Agency for Research on Cancer (IARC) predicts that by 2040, the global burden of cancer would have increased to 27.5 million new cancer cases and 16.3 million deaths. Furthermore, single-cell analysis market is projected to standardise and automate workflows in clinical diagnostics, providing significant information for real-time cancer monitoring and, eventually, new therapeutic methods for the benefit of patients. This feature is expected to result in more effective and thorough analysis. As a result, increased spending in cancer research is expected to be one of the market’s primary driving forces over the forecast period. The high cost of single-cell analysis devices, on the other hand, is projected to limit the market’s expansion.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX